Matches in Nanopublications for { ?s ?p "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP156275.RAZRB5tdRmx4qDNZtnnY_RfPUOJC1uBhuMjqKZV0xvVyU130_assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156275.RAZRB5tdRmx4qDNZtnnY_RfPUOJC1uBhuMjqKZV0xvVyU130_provenance.
- assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP789779.RACCFEo7bjR6r4Hr6SRGzOOSKYnpsNyVlRytoYHUmK53A130_assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789779.RACCFEo7bjR6r4Hr6SRGzOOSKYnpsNyVlRytoYHUmK53A130_provenance.
- NP789778.RAfx82yXokHVkkArZPiDkE9K6h003vG3FByQv5UvDioqY130_assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789778.RAfx82yXokHVkkArZPiDkE9K6h003vG3FByQv5UvDioqY130_provenance.
- NP789777.RAHlqyZqyESsGbaDsQyN4uT8GzRJoMjTP2-vBHoHP9kIY130_assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789777.RAHlqyZqyESsGbaDsQyN4uT8GzRJoMjTP2-vBHoHP9kIY130_provenance.
- NP789781.RA-_qnvf7-95bvEsbEi5goJVB0Otm4f1JtsqIdH_5ByN8130_assertion description "[BRCA1 and BRCA2 screening in women at high-risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789781.RA-_qnvf7-95bvEsbEi5goJVB0Otm4f1JtsqIdH_5ByN8130_provenance.